VanEck Strengthens Smart Contracts Focus With ETN Launch in Europe; Continues Global Expansion of Digital Assets Lineup
ETN is VanEck’s latest offering focused on smart contracts, a segment of the digital assets…
ETN is VanEck’s latest offering focused on smart contracts, a segment of the digital assets…
As leaders look to the future, further embedding quality improvement approaches in everyday systems and…
SAN DIEGO–(BUSINESS WIRE)–Mortgage banker American Mortgage Network (AmNet), a 100% employee-owned company (ESOP), announced today…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–SentinelOne (NYSE: S), an autonomous cybersecurity platform company, announced today that it…
Six new advisors include leading experts in pathology, oncology, deep learning and global biopharmaceutical industry…
HERNDON, Va.–(BUSINESS WIRE)–Iron Bow Technologies, an information technology solutions provider to government, commercial, education, and…
PRO ranked highly for the universal strength of its Integrated Workforce Management platform comprised of…
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
SUNNYVALE, Calif., May 04, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular…
Product theater presentation will be held on May 7 to highlight clinical data and attributes…
CAMARILLO, Calif., May 04, 2022 (GLOBE NEWSWIRE) — Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech…
SAN DIEGO and SUZHOU, China and SHANGHAI, China, May 04, 2022 (GLOBE NEWSWIRE) — Gracell…
SAN DIEGO, May 04, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage…
Upfront payment of $100 million, an additional $160 million available upon FDA approval of vonoprazan…
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
ZUG, Switzerland and CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Statistically significant increase in innate and adaptive immune response biomarkers (monocyte and CD8 T cell…
SOUTH SAN FRANCISCO, Calif., May 04, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
NEWTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…